Resyca BV is a joint venture of Recipharm AB and Medspray BV and offers fast and efficient soft-mist inhalers to pharma. Resyca BV was founded in 2020 and is a joint venture between Bespak and Medspray. The company focuses on developing and manufacturing pocket size, user friendly soft-mist inhalation devices and soft nasal sprays, based on standard pre-filled syringe and filled on standard filling lines. It operates as a soft mist development center with Recipharm and offers an end-to-end service for soft-mist inhalation and nasal delivery products, ranging from early-stage development to commercial manufacture, including filling, labeling, and packaging. Headquartered in The Netherlands, Resyca is positioned to leverage its expertise and strategic partnerships for innovative solutions in the healthcare industry. With its unique offering and strong backing of established companies, Resyca holds promising potential for growth and success in the competitive pharmaceutical market.
